Brief: Knight Therapeutics Submits Crexont® (Carbidopa And Levodopa) Extended-Release Capsules In Mexico
05/08/2025 13:28
Aug 5 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: KNIGHT THERAPEUTICS ANNOUNCES REGULATORY SUBMISSION OF CREXONT® (CARBIDOPA AND LEVODOPA) EXTENDED-RELEASE CAPSULES IN MEXICO Source text: ID:nGNXc1N94q Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study